Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MPW stock price vs PCH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PCH's multiple
Needs PCH P/S.
Implied fair value · at MPW's multiple
Needs MPW P/S.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
16 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MEDICAL PROPERTIES TRUST INC · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
POTLATCHDELTIC CORP · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Sabra Health Care REIT, Inc.
MPW vs SBRA
WELLTOWER INC.
MPW vs WELL
Ventas, Inc.
MPW vs VTR
NATIONAL HEALTH INVESTORS INC
MPW vs NHI
OMEGA HEALTHCARE INVESTORS INC
MPW vs OHI
LTC PROPERTIES INC
MPW vs LTC
WEYERHAEUSER CO
MPW vs WY
RAYONIER INC
MPW vs RYN
SIMMONS FIRST NATIONAL CORP
MPW vs SFNC
ANNALY CAPITAL MANAGEMENT INC
MPW vs NLY
AGNC Investment Corp.
MPW vs AGNC
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe MPW can stabilize earnings and reduce leverage meaningfully, then consider it only as a turnaround case because the current data show negative net income, declining revenue, and very high net debt/EBITDA versus PCH.
No live price, P/S, or EV-based valuation is provided, so the relative valuation case cannot be anchored to an actual market discount or premium. The only explicit valuation reference is the DCF range of $3.09-$4.18, which suggests any view on MPW must be framed around intrinsic value rather than current trading multiples.
Supporting Metrics
